Agoracom Blog Home

Posts Tagged ‘small cap stocks’

« Older Entries
Newer Entries »

Datametrex $DM.ca Co-Bid With #Lotte To The Ministry of Health Surrounding #Covid19

Posted by AGORACOM-JC at 7:30 AM on Monday, April 6th, 2020
  • Established a join venture (JV) with LOTTE to co-bid on contracts with the Ministry of Health in South Korea
  • This is to improve accuracy and transparency in the middle of COVID-19 catastrophe on media, social media, and various other data sources

TORONTO, April 06, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) is pleased to announce that it has established a join venture (JV) with LOTTE to co-bid on contracts with the Ministry of Health in South Korea. This is to improve accuracy and transparency in the middle of COVID-19 catastrophe on media, social media, and various other data sources.

On April 2, 2020, Datametrex announced that it was awarded preferred vendor status with LOTTE. One of the many benefits of being a preferred vendor is the opportunity to create JV’s and co-bid on contracts with LOTTE’s support. Datametrex and LOTTE recently agreed to create a JV using its AI and other relevant technologies to improve the accuracy and transparency of data which includes ability to filter disinformation for the Ministry of Health Department in South Korea. This opportunity was initiated due to the Coronavirus and COVID-19 catastrophe. South Korea’s health department has been the leader in screening and flattening the curve and is a role model for other countries on how to manage the COVID-19 pandemic.

The Company was successful in pitching the opportunity and create a JV with LOTTE largely due to the work it has done for the US Federal Government on COVID-19 and Coronavirus.   Datametrex released a report on April 1, 2020 which clearly identified Chinese authorities manipulating social media surrounding Coronavirus and COVID-19. Their intent was to sway public opinion to negatively impact the United States Government and President Trump while positively impacting China and President Xi.

Please click the link below to view the report:

http://datametrex.com/investor/covid19-report.html

“I am thrilled to share this update with shareholders, our team has done a fantastic job fast tracking with LOTTE. The work we have done this past year training our technology in various languages such as Korean, Chinese, French, and Russian is really starting to pay off,” says Marshall Gunter, CEO of the Company

About Datametrex AI Limited

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com).
Additional information on Datametrex is available at: www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Jeff Stevens- Co-Founder
Phone: (647) 400-8494
Email: [email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , , ,
Posted in All Recent Posts, Datametrex AI Limited | Comments Off on Datametrex $DM.ca Co-Bid With #Lotte To The Ministry of Health Surrounding #Covid19

Social Media Is Full of Bots Spreading #COVID19 Anxiety. Don’t Fall For It – SPONSOR: Datametrex AI Limited $DM.ca

Posted by AGORACOM-JC at 3:52 PM on Friday, April 3rd, 2020

SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company is working with US Government agencies on Covid19 and Coronavirus fake news and disinformation Click here for more info.

Social Media Is Full of Bots Spreading COVID-19 Anxiety. Don’t Fall For It

  • COVID-19 is being described as the first major pandemic of the social media age.
  • In troubling times, social media helps distribute vital knowledge to the masses.
  • Unfortunately, this comes with myriad misinformation, much of which is spread through social media bots.

These fake accounts are common on Twitter, Facebook, and Instagram. They have one goal: to spread fear and fake news.

We witnessed this in the 2016 United States presidential elections, with arson rumours in the bushfire crisis, and we’re seeing it again in relation to the coronavirus pandemic.

Busy busting bots

The exact scale of misinformation is difficult to measure. But its global presence can be felt through snapshots of Twitter bot involvement in COVID-19-related hashtag activity.

Bot Sentinel is a website that uses machine learning to identify potential Twitter bots, using a score and rating. According to the site, on March 26 bot accounts were responsible for 828 counts of #coronavirus, 544 counts of #COVID19 and 255 counts of #Coronavirus hashtags within 24 hours.

These hashtags respectively took the 1st, 3rd and 7th positions of all top-trolled Twitter hashtags.

It’s important to note the actual number of coronavirus-related bot tweets are likely much higher, as Bot Sentinel only recognises hashtag terms (such as #coronavirus), and wouldn’t pick up on “coronavirus”, “COVID19” or “Coronavirus”.

How are bots created?

Bots are usually managed by automated programs called bot “campaigns”, and these are controlled by human users.

The actual process of creating such a campaign is relatively simple. There are several websites that teach people how to do this for “marketing” purposes. In the underground hacker economy on the dark web, such services are available for hire.

While it’s difficult to attribute bots to the humans controlling them, the purpose of bot campaigns is obvious: create social disorder by spreading misinformation. This can increase public anxiety, frustration and anger against authorities in certain situations.

A 2019 report published by researchers from the Oxford Internet Institute revealed a worrying trend in organised “social media manipulation by governments and political parties”. They reported:

Evidence of organised social media manipulation campaigns which have taken place in 70 countries, up from 48 countries in 2018 and 28 countries in 2017. In each country, there is at least one political party or government agency using social media to shape public attitudes domestically.

The modus operandi of bots

Typically, in the context of COVID-19 messages, bots would spread misinformation through two main techniques.

The first involves content creation, wherein bots start new posts with pictures that validate or mirror existing worldwide trends. Examples include pictures of shopping baskets filled with food, or hoarders emptying supermarket shelves. This generates anxiety and confirms what people are reading from other sources.

The second technique involves content augmentation. In this, bots latch onto official government feeds and news sites to sow discord. They retweet alarming tweets or add false comments and information in a bid to stoke fear and anger among users. It’s common to see bots talking about a “frustrating event”, or some social injustice faced by their “loved ones”.

The example below shows a Twitter post from Queensland Health’s official twitter page, followed by comments from accounts named “Sharon” and “Sara” which I have identified as bot accounts. Many real users reading Sara’s post would undoubtedly feel a sense of injustice on behalf of her “mum”.

The official tweet from Queensland Health and the bots’ responses.

While we can’t be 100 percent certain these are bot accounts, many factors point to this very likely being the case. Our ability to accurately identify bots will get better as machine learning algorithms in programs such as Bot Sentinel improve.

How to spot a bot

To learn the characteristics of a bot, let’s take a closer look Sharon’s and Sara’s accounts.

Screenshots of the accounts of ‘Sharon’ and ‘Sara’.

Both profiles lack human uniqueness, and display some telltale signs they may be bots:

  • they have no followers
  • they only recently joined Twitter
  • they have no last names, and have alphanumeric handles (such as Sara89629382)
  • they have only tweeted a few times
  • their posts have one theme: spreading alarmist comments
  • they mostly follow news sites, government authorities, or human users who are highly influential in a certain subject (in this case, virology and medicine).

My investigation into Sharon revealed the bot had attempted to exacerbate anger on a news article about the federal government’s coronavirus response.

The language: “Health can’t wait. Economic (sic) can” indicates a potentially non-native English speaker.

It seems Sharon was trying to stoke the flames of public anger by calling out “bad decisions”.

Looking through Sharon’s tweets, I discovered Sharon’s friend “Mel”, another bot with its own programmed agenda.

Bot ‘Mel’ spread false information about a possible delay in COVID-19 results, and retweeted hateful messages.

What was concerning was that a human user was engaging with Mel.

An account that seemed to belong to a real Twitter user began engaging with ‘Mel’.

You can help tackle misinformation

Currently, it’s simply too hard to attribute the true source of bot-driven misinformation campaigns. This can only be achieved with the full cooperation of social media companies.

The motives of a bot campaign can range from creating mischief to exercising geopolitical control. And some researchers still can’t agree on what exactly constitutes a “bot”.

But one thing is for sure: Australia needs to develop legislation and mechanisms to detect and stop these automated culprits. Organisations running legitimate social media campaigns should dedicate time to using a bot detection tool to weed out and report fake accounts.

And as a social media user in the age of the coronavirus, you can also help by reporting suspicious accounts. The last thing we need is malicious parties making an already worrying crisis worse.

Ryan Ko, Chair Professor and Director of Cyber Security, The University of Queensland.

Source: https://www.sciencealert.com/bots-are-causing-anxiety-by-spreading-coronavirus-misinformation

Tags: , , , , , ,
Posted in Datametrex AI Limited | Comments Off on Social Media Is Full of Bots Spreading #COVID19 Anxiety. Don’t Fall For It – SPONSOR: Datametrex AI Limited $DM.ca

CLIENT FEATURE: CardioComm Solutions $EKG.ca – Putting Your Heartbeat Into The Cloud For Instant Diagnostics $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 12:40 PM on Friday, April 3rd, 2020

Global Leaders in Mobile  ECG Connectivity

  • 20 years of medical credibility licensing technologies to hospitals, physicians, remote patient monitoring  platforms, research groups and commercial call centers
  • Sold into > 20 countries, with the largest customer base located in the US
  • Class II medical device clearances and device agnostic for collecting, viewing, recording, analyzing and  storing of ECGs for management of patient and consumer health
  • ECG solutions for both consumer (OTC) and medical (Rx) markets
  • Owns all IP and source code
  • Market expert contributor for reports in m‐health, mobile cardiac monitoring and new advances in  consumer health and wellness monitoring

Recent Highlights

CardioComm Solutions Partners with CareOS to Bring Consumer ECG Monitoring into the Connected Home

  • Entered into a partnership agreement with CareOS SAS (France), a subsidiary of Baracoda Group, to provide consumer ECG monitoring technologies through the CareOS Poseidon smart mirror health and beauty hub
  • The partnership will see CardioComm’s FDA and Health Canada cleared GEMS™ ECG management software and Smart Monitoring ECG reading service integrated into the touch and gesture controlled smart mirror
  • GEMSTM software will be capable of recognizing ECG devices made by multiple device manufacturers which will permit CareOS customers more options in choosing a device of their preference.

Industry News

Company Accolades

FULL DISCLOSURE: CardioComm Solutions Inc. is an advertising client of AGORA Internet Relations Corp.

Tags: , , , , ,
Posted in All Recent Posts, CardioComm Solutions | Comments Off on CLIENT FEATURE: CardioComm Solutions $EKG.ca – Putting Your Heartbeat Into The Cloud For Instant Diagnostics $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Datametrex $DM.ca Builds Dashboard To Monitor Global Covid-19 Pandemic

Posted by AGORACOM-JC at 7:33 AM on Friday, April 3rd, 2020
  • Completed an interactive COVID-19 dashboard to help with the understanding of the danger of this virus, and to monitor the global impact of COVID-19
  • The dashboard was built to incorporate data that has been collected from various countries and organizations including World Health Organization

TORONTO, April 03, 2020 – Datametrex AI Limited (the “Company” or “Datametrex”) is pleased to announce that it has completed an interactive COVID-19 dashboard to help with the understanding of the danger of this virus, and to monitor the global impact of COVID-19. The dashboard was built to incorporate data that has been collected from various countries and organizations including World Health Organization (“WHO”). It is analyzed and presented in a user-friendly format which allows users to easily examine the spread of COVID-19 globally, by country or to compare various countries.

http://www.datametrex.com/covid-board.html

“As an AI company, we felt it important to provide access to a platform like this so people can see the real time effects of the COVID-19 pandemic. We’ve had a lot of interest from people looking for more data surrounding the Coronavirus and COVID-19 as a result of the work we are doing for the United States Government. It was from this that we decided to build a user friendly dashboard that allows people to see the global impact. We produce more than just reports,” says Marshall Gunter, CEO of the Company.

About Datametrex AI Limited

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com).

Additional information on Datametrex is available at: www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , , , ,
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca Builds Dashboard To Monitor Global Covid-19 Pandemic

Have the next crop of #battery metals producers been oversold? – SPONSOR Tartisan #Nickel $TN.ca – $ROX.ca $FF.ca $EDG.ca $AGL.ca $ANZ.ca

Posted by AGORACOM-JC at 1:27 PM on Thursday, April 2nd, 2020

SPONSOR: Tartisan Nickel (TN:CSE)  Kenbridge Property has a measured and indicated resource of 7.14 million tonnes at 0.62% nickel, 0.33% copper. Tartisan also has interests in Peru, including a 20 percent equity stake in Eloro Resources and 2 percent NSR in their La Victoria property. Click her for more information

Tc logo in black

Have the next crop of battery metals producers been oversold?

  • Could a large global recession as a result of the COVID-19 crisis alter the consensus long term outlook for battery raw materials like lithium, cobalt, graphite, nickel and copper?
  • No, says CRU Group senior analyst George Heppel. Irrespective of temporary recessions or market downturns, electrification of the global automotive sector remains “inevitable” in the long run.

By: Reuben Adams

Right now, COVID-19 is freezing the embryonic battery supply chain. But for the next crop of battery metals producers — impacted by the broader share market rout — ‘deals and discussions’ are very much continuing behind the scenes.

The short-term outlook for the lithium-ion supply chain, like everything else, is uncertain. Could a large global recession as a result of the COVID-19 crisis alter the consensus long term outlook for battery raw materials like lithium, cobalt, graphite, nickel and copper?

No, says CRU Group senior analyst George Heppel. Irrespective of temporary recessions or market downturns, electrification of the global automotive sector remains “inevitable” in the long run.

“Investment in e-mobility reduces CO2 emissions, improves air quality and will eventually make a huge amount of financial sense to the average consumer as battery costs decline and manufacturing scale ramps up,” he says.

The future remains bright for high quality battery facing stocks, especially those placed to take advantage of the next upsurge in demand in 2022/2023.

In the short-term, Heppel says the automotive sector – and EVs by extension – are experiencing a reduction in demand due to quarantine.

“Many consumers in key markets can’t leave their house for non-essential reasons right now, let alone buy cars,” he says.

“We have heard reports that 85 per cent of automotive manufacturing capacity in Germany is currently idle as a result of the pandemic.

“However, in theory this should create ‘pent up demand’ which is released when quarantines are relaxed.”

Ongoing economic uncertainty will also hinder attempts to push new battery metals projects into production in the short-term, Benchmark Mineral Intelligence analyst Andrew Miller says.

“As a result, the potential for a supply crunch over the coming years will increase – money needs to go into new expansions today to fuel the growth in EV production in 2022/23 onwards,” he says.

Battery focused nickel sulphide play Blackstone Minerals (ASX:BSX) agrees that supply will tighten due to the reduced funding into new projects going forward “which will reduce the supply of nickel (particularly from laterites) and only increase the gap between supply and demand”.

“Tread carefully, but I believe now is the time to be buying those mining stocks you’ve been watching for months,” Blackstone managing director Scott Williamson told Stockhead.

“I can’t see the junior battery metals miners getting any cheaper than they are today.”

EV ‘engine room’ China is rebounding already

As the “backbone of the EV market to date”, China’s apparent early economic recovery from COVID-19 will help support the battery supply chain, Miller says.

“What was meant to be the year battery demand diversified outside China may now see China play a more important role than ever before,” he says.

“There are also expectations that EVs will be included in the country’s stimulus efforts which could bolster the long-term outlook.”

China moving to insulate domestic #EV market as the country’s supply chain ramps back up following Q1 slowdown. More of these types of policies likely to follow over coming months: https://t.co/XUea3iteT5

— Andrew Miller (@amiller_bmi) March 31, 2020

Advanced explorer AVZ Minerals (ASX:AVZ) is driving the mammoth Manono project in the DRC toward a development decision.

As part of that process, it is aiming to lock in a lithium offtake and strategic investment deal with Chinese firm Yibin Tianyi.

Yibin Tianyi is set to become a key cog in the supply chain of Contemporary Amperex Technology (CATL), the world’s biggest lithium-ion battery maker.

In late March,  Yibin Tianyi signed a new five-year, 75,000-tonne-per-annum (tpa) offtake agreement with WA producer Pilbara Minerals (ASX:PLS).

AVZ managing director Nigel Ferguson told Stockhead the company had seen “increased and faster responses” out of the companies they were talking to in China over the last few weeks.

“They appear to be re-awakening after the significant lock downs there,” he says.

“OEM/car manufacturers are committed to their EV plans, and while the current events are certainly causing disruptions, I have not heard of any OEM changing its long-term EV growth plans.

“For AVZ, with our significant long-life, high-quality resource underpinned by the EV thematic, the future is very bright. Current share price values certainly do not represent that.”

Source: https://stockhead.com.au/resources/have-the-next-crop-of-battery-metals-producers-been-oversold/

Tags: , , , ,
Posted in All Recent Posts, Tartisan Nickel | Comments Off on Have the next crop of #battery metals producers been oversold? – SPONSOR Tartisan #Nickel $TN.ca – $ROX.ca $FF.ca $EDG.ca $AGL.ca $ANZ.ca

VIDEO: #Datametrex $DM.ca #AI Hired By US Government Agencies On #COVID19 / #Coronavirus Fake News and Disinformation

Posted by AGORACOM-JC at 5:13 PM on Wednesday, April 1st, 2020

When US Government Agencies call you in the middle of the greatest health and economic crisis in 100 years, it is safe to assume your Artificial Intelligence capabilities to detect fake news, disinformation campaigns and their impact is amongst the most respected in the world.  

You would expect such a company to be a tech giant or a Silicon Valley project.  But Datametrex AI (DM: TSXV) (Soon To Be Nexaology) is a great Canadian small cap technology company, that has also achieved the following as of late:

  • Q3 Revenues Of $1.6 million,  an increase of 186%
  • 9 Mont Revenues Of $2.56M an increase of 37%
  • Repeat Contracts Of $1M and $600,000 With Korean Giant LOTTE   
  • $954,000 Contract With Canadian Department of Defence To Fight Social Media Election Meddling
  • Participation In NATO Research Task Group On Social Media Threat Detection 
  • Becoming an affiliate member of the Carnegie Mellon University Center for IDeaS

When a small cap Artificial Intelligence company is successfully deploying its technology with military and conglomerates, smart investors have to take a closer look.  

That look can begin with our latest interview of Datametrex CEO, Marshall Gunter, who talks to us about the use of the Company’s Artificial Intelligence by US Government Agencies to detect misinformation campaigns against the United States by foreign entities.  

Watch this interview on one of your favourite screens or hit play and listen to the audio as you drive. 

Tags: , , , , , ,
Posted in AGORACOM Via Satellite, Datametrex AI Limited, Featured | Comments Off on VIDEO: #Datametrex $DM.ca #AI Hired By US Government Agencies On #COVID19 / #Coronavirus Fake News and Disinformation

#Mhealth Project to Crowdsource Consumer Data for #Coronavirus Research – SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 11:49 AM on Wednesday, April 1st, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

mHealth Project to Crowdsource Consumer Data for Coronavirus Research

  • UCSF researchers are deploying an mHealth app to gather information on daily health habits
  • They’re hoping to gain insight on how behaviors might affect the course of the virus or outcomes in those who are infected

By Eric Wicklund

March 31, 2020 – mHealth researchers are using smartphones to crowdsource Coronavirus research.

The University of California at San Francisco has launched COVID-19 Citizen Science (CCS), a project aimed at gathering insights from people around the world on the virus. Participants are being asked to download an mHealth app, complete a survey about their daily health habits, complete a weekly follow-up survey and pass it on to friends.

“We are asking each participant to share the link to recruit at least five others,” Gregory Marcus, MD, MAS, a professor at UCSF’s Department of Medicine and the project’s co-leader, said in a press release. “We want to demonstrate that the number of people signing up for this scientific study and contributing their data can increase exponentially, faster than the disease itself.”

Participants will also be able to provide continuous GPS data and information from mHealth wearables, such as Fitbit activity bands and smartwatches.

(For more coronavirus updates, visit our resource page, updated twice daily by Xtelligent Healthcare Media.)

The program is one of several aimed at using connected health platforms to study the pandemic. Just down the highway in San Diego, the Scripps Research Translational Institute has launched a project aimed at measuring the value of mHealth wearables in detecting emerging viral outbreaks.

Another project launched out of UCSF, meanwhile, is using mHealth wearables to monitor frontline care workers who’ve been exposed to the virus.

Marcos is no stranger to telehealth projects. In 2013 he helped to launch the Health eHeart Study, which used online and mHealth tools to collect and analyze heart health data. That, in turn, led to the launch of a study in 2018 that combined mHealth wearables with AI to determine whether a cardiac monitoring platform could help detect early signs of diabetes.

Marcos says CCS aims to identify behaviors, influences and factors that might affect the course of the virus and outcomes after infection, and he feels the study could be the largest-ever prospective epidemiological study of infectious diseases.

“Social distancing keeps many protected,” he said, “but joining together to contribute data will help us beat this thing.”

Source: https://mhealthintelligence.com/news/mhealth-project-to-crowdsource-consumer-data-for-coronavirus-research

Tags: , , , , , ,
Posted in All Recent Posts, CardioComm Solutions | Comments Off on #Mhealth Project to Crowdsource Consumer Data for #Coronavirus Research – SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

PyroGenesis $PYR.ca Receives $550K Under an Exclusive Agreement with a US Tunneling Company $RTN $NOC $UTX $HPQ.ca $DDD.ca $SSYS $PRLB

Posted by AGORACOM-JC at 10:18 AM on Wednesday, April 1st, 2020
  • Announced today that it has received US$400K (approx. CA $550K) under an exclusive agreement with a US based tunneling company
  • The Client’s name will remain anonymous for confidentiality and competitive reasons
  • “Yes, this is a new agreement. Yes, it has nothing to do with the pandemic. Yes, it can be executed under the current travel and work-from-home restrictions, and yes it has all the makings of a long-term relationship,” said Mr. Peter Pascali, CEO of PyroGenesis Canada Inc.

MONTREAL, April 01, 2020 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch systems, is pleased to announce today that it has received US$400K (approx. CA $550K) under an exclusive agreement (the “Agreement”) with a US based tunneling company (the “Client”). The Client’s name will remain anonymous for confidentiality and competitive reasons.

“Yes, this is a new agreement. Yes, it has nothing to do with the pandemic. Yes, it can be executed under the current travel and work-from-home restrictions, and yes it has all the makings of a long-term relationship,” said Mr. Peter Pascali, CEO of PyroGenesis Canada Inc. “We are proud to be able to announce this relationship, particularly given the current environment where investors are more focused on multiple secure revenue streams. It is important to underscore the fact that this relationship was not born out of the current crisis and, as such, is expected to continue well after the pandemic is behind us.”

In the scope of work, currently being defined under this Agreement, PyroGenesis will not only develop and supply high-powered plasma torches, specifically designed for tunneling applications, but will also be intimately involved in all aspects of design and development for the entire project. Upon success, the Client is committed to purchase exclusively, and PyroGenesis is committed to exclusively supplying, plasma torches and auxiliary equipment for these applications. The scope of work will be comprised of several phases, each defined by the results from the former. The Company has received an initial down payment of US$400K (approx. CA $550K) under this Agreement.

PyroGenesis’ high-powered plasma torch will be used to replace traditional tunneling methods. An important benefit in using plasma-based tools versus traditional methods, is its potential to drill through all geologies with greater flexibility in size diameter, while at the same time being more economical, efficient and environmentally friendly.

“This Agreement, once again, underscores our plasma torch expertise, and we are pleased to be applying it to a very unique and significant opportunity,” said Mr. Alex Pascali, Business Development Manager of PyroGenesis. “This highlights the fact that we not only sell plasma torches, but also provide the expertise required to develop cutting edge plasma-based applications. The Company continues to increase revenues and reduce risk by diversifying its customer base with a standard product offering. This is just one of many exciting developments at PyroGenesis these days.”

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc., a high-tech company, is the world leader in the design, development, manufacture and commercialization of advanced plasma processes and products. We provide engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2015 and AS9100D certified, and have been since 1997. PyroGenesis is a publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws. Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

For further information please contact:
Rodayna Kafal, Vice President Investors Relations and Strategic Business Development
Phone: (514) 937-0002, E-mail: [email protected]
www.pyrogenesis.com

Tags: , , ,
Posted in PyroGenesis Canada Inc. | Comments Off on PyroGenesis $PYR.ca Receives $550K Under an Exclusive Agreement with a US Tunneling Company $RTN $NOC $UTX $HPQ.ca $DDD.ca $SSYS $PRLB

Empower Clinics $CBDT.ca Announces March 2020 Patient Growth Of 593% and 1Q 2020 Visits Increasing By 478% $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 7:21 AM on Wednesday, April 1st, 2020
  • Announced that patient visits in corporate clinics increased by 593%% in March 2020 versus the same period in 2019,
  • total patient visits of 2,160 in March 2020 compared to 364 in March 2019
  • 1Q 2020 patient visits increased by 478% versus the same period 2019, with total patient visits of 5,717 in 1Q 2020 compared to 1,196 in 1Q 2019.

VANCOUVER, BC / April 1, 2020 / EMPOWER CLINICS INC. (CSE: CBDT) (OTC: EPWCF) (Frankfurt 8EC) (“Empower” or the “Company”), a vertically integrated and growth-oriented life sciences company, is pleased to announce that patient visits in corporate clinics increased by 593%% in March 2020 versus the same period in 2019, with total patient visits of 2,160 in March 2020 compared to 364 in March 2019.

1Q 2020 patient visits increased by 478% versus the same period 2019, with total patient visits of 5,717 in 1Q 2020 compared to 1,196 in 1Q 2019.

“These are unprecedented times, yet our team members remain dedicated to supporting patients every day, at record levels, using new operational techniques and safety protocols” said Steven McAuley, Chairman & CEO of Empower. “I am so proud of our management, our staff’s willingness to adjust to changing times, and our commitment to the daily needs of patients.”

The Company has also entered into to a new tele-medicine service agreement that will provide access to our physicians across multiple states, offering current and new modalities to existing and new patients. Additional announcements about the Company’s digital health initiatives will be forthcoming.

The Company has also issued a total of 600,000 stock options priced at $0.05 CAD to investor relation service providers and to a Director of the Company.

ABOUT EMPOWER

Empower is a vertically-integrated health & wellness brand with it’s first hemp-derived CBD extraction facility under development, the Company produces its proprietary line of cannabidiol (CBD) based products and distributes products through company owned and franchised clinics, with wholesale partnerships, online channels and with new retail opportunities nationwide in the U.S. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors:Steven McAuley

CEO

[email protected]

604-789-2146

Investors:

Dustin Klein
SVP, Business Development

[email protected]

720-352-1398

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

Tags: , , , , ,
Posted in Empower Clinics Inc., Featured | Comments Off on Empower Clinics $CBDT.ca Announces March 2020 Patient Growth Of 593% and 1Q 2020 Visits Increasing By 478% $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

‘Smart’ devices help reduce adverse outcomes of common heart condition #Mhealth – SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 4:02 PM on Tuesday, March 31st, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

‘Smart’ devices help reduce adverse outcomes of common heart condition

  • mHealth devices, such as fitness trackers, smart watches and mobile phones, may enable earlier AF detection, and improved AF management through the use of photoplethysmography (PPG) technology
  • AF is the most common heart rhythm disturbance, affecting around one million people in the UK. People with AF are at increased risk of having a stroke and dying, as well as heart failure and dementia

by University of Liverpool

A new study, published in the Journal of the American College of Cardiology, highlights the feasible use of mobile health (mHealth) devices to help with the screening and detection of a common heart condition.

Atrial fibrillation (AF) is a heart rhythm condition that causes an irregular and sometimes, abnormally fast heart rate. In AF, the heart’s upper chambers (atria) contract randomly and sometimes so fast that the heart muscle cannot relax properly between contractions. This reduces the heart’s efficiency and performance—but also leads to a higher risk of blood clots.

AF is the most common heart rhythm disturbance, affecting around one million people in the UK. People with AF are at increased risk of having a stroke and dying, as well as heart failure and dementia. Currently, low detection due to lack of visible symptoms and non-adherence are major problems in current management approaches for patients with suspected AF.

Photoplethysmography technology

mHealth devices, such as fitness trackers, smart watches and mobile phones, may enable earlier AF detection, and improved AF management through the use of photoplethysmography (PPG) technology.

PPG is a simple and low-cost optical technique that can be used to detect blood volume changes in the microvascular bed of tissue. It is often used non-invasively to make measurements at the skin surface.

To help determine whether a mHealth technology-supported AF integrated management strategy would reduce AF-related adverse events, compared to usual care, an international team of researchers, led by Associate Professor Guo from Chinese PLA General Hospital in Beijing, and Professor Gregory Lip, Lead for the Liverpool Centre for Cardiovascular Science (LCCC)/Price-Evans Chair of Cardiovascular Medicine at University of Liverpool, conducted a randomised trial.

Central to the study was mobile health technologies developed by leading global technology companies, with a focus on using wearable smart devices such as those from Huawei, working in conjunction with a specially developed mobile app. These pieces of equipment and software can monitor a person’s vital signs with great detail and, most importantly for this study, 24 hours a day.

The specially designed mobile app not only charted the patient’s biometrics, it afforded clinicians the ability to offer integrated care throughout the duration of the trial. Doctors were able to periodically assess the patient’s updated statistics and contact them through the app to offer advice via the ABC care pathway. The ABC pathway, developed in part by the LCCS’ Professor Gregory Lip, is a set of guidance for patients and clinicians, which aims to promote a streamlined holistic approach to the management of AF, and ensure that the danger of complications is minimised.

The researchers enrolled a cluster of 3,324 AF patients aged over 18 years from 40 cities across China. The patients were randomized with 1678 receiving usual care and 1646 receiving integrated care based on a mobile AF Application (mAFA) incorporating the ABC Pathway: ‘A’ Avoid stroke; ‘B’ Better symptom management; ‘C’ Cardiovascular and other comorbidity risk reduction. All patients were followed up in outpatient clinics at 6 and 12 months.

Results

Upon completion of the study, the researchers were able to show that occurrences of stroke, systemic thromboembolism, death and rehospitalisation were significantly lower with those patients in the mHealth intervention group compared to those undergoing usual care (1.9% compared with 6%). Rehospitalisation rates were also notably reduced, with only 1.2% of patients in the intervention group needing to be readmitted to hospital, in comparison to 4.5% of patients in the control group.

In addition to these positive figures, subgroup analyses by gender, age, type of condition, risk score and comorbidities, demonstrated consistently lower risks for the composite outcome for patients receiving the mAFA intervention compared to usual care.

These results show an undeniable benefit for the adoption of an integrated approach to monitoring and treating cardiac conditions such as AF.

With smart technologies such as phones, watches and integrated smart home systems becoming increasingly accessible and affordable, the ability for clinicians and researchers to adopt this technology to passively and unobtrusively gather a seemingly unlimited amount of data and information on the global health population is offering boundless opportunity for assessing and treating all manner of diseases and conditions.

Integrated care approach

Associate Professor Guo, said: “Our study clearly highlights the need for an integrated care approach to holistic AF care, supported by mobile health technology, as it help to reduce the risks of rehospitalisation and clinical adverse events.”

Professor Lip, said: “Improved AF care requires early detection which enables the implementation of the priorities of AF management, which is as ‘easy as ABC’: Avoid stroke; Better symptom optimisation; Cardiovascular and risk factor management. Our clinical trial shows how the mAFA App and smart devices can improve detection of AF and the holistic management of AF patients, improving outcomes in this common heart rhythm disorder.”

Source: https://medicalxpress.com/news/2020-03-smart-devices-adverse-outcomes-common.html

Tags: , , , , , , ,
Posted in CardioComm Solutions | Comments Off on ‘Smart’ devices help reduce adverse outcomes of common heart condition #Mhealth – SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

« Older Entries
Newer Entries »